Kmpharmaceutical Co (XKRX:225430) Net Income (Continuing Operations) : ₩-1,320 Mil (TTM As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Kmpharmaceutical Co Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Kmpharmaceutical Co's Net Income (Continuing Operations) for the three months ended in Dec. 2023 was ₩-949 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-1,320 Mil.

Kmpharmaceutical Co Net Income (Continuing Operations) Historical Data

The historical data trend for Kmpharmaceutical Co's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kmpharmaceutical Co Net Income (Continuing Operations) Chart

Kmpharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income (Continuing Operations)

Get a 7-Day Free Trial

-902.23

470.88

-611.19

-3,924.97

-1,320.04

Kmpharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Income (Continuing Operations)	Get a 7-Day Free Trial															-2,404.39	-19.42	158.72	-510.66	-948.68

Kmpharmaceutical Co Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-1,320 Mil.

Kmpharmaceutical Co (XKRX:225430) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Kmpharmaceutical Co Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Kmpharmaceutical Co's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Kmpharmaceutical Co (XKRX:225430) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Kmpharmaceutical Co Ltd (XKRX:225430) » Definitions » Net Income (Continuing Operations)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Six road-dong, Yeongdeungpo-gu, Triple-floor building 6, Seoul International Finance 11 (dong), Seoul, KOR, 07330

Website

Kmpharmaceutical Co Ltd, formerly IBKS No.3 Special Purpose Acquisition Co is engaged in auxiliary to financial service activities.

Kmpharmaceutical Co (XKRX:225430) Headlines

No Headlines